Wire
EUDA Health Signs MOU With GO POSB Organoids, Shenzhen Inno on Induced Pluripotent Stem Cell Therapies
EUDA Health (EUDA) said Tuesday it signed a memorandum of understanding to establish a collaboration with GO POSB Organoids and Shenzhen Innovation Immunotechnology on next-generation therapies derived from induced pluripotent stem cells.The parties plan to collaborate on the development, manufacturing and commercialization of off-the-shelf oncology cell therapies for cancer-treatment and wellness applications, according to a statement.Price: $20.00, Change: $+1.00, Percent Change: +5.26%
$EUDA
